|Articles|February 11, 2022
- Applied Clinical Trials-02-01-2022
- Volume 31
- Issue 1/2
Applied Clinical Trials January/February 2022 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials January/February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 3 years ago
Tech Integration for Clinical Trialsover 3 years ago
Integrating Technology and Expertiseover 3 years ago
Salary Survey: The Age of COVIDover 3 years ago
A(nother) New Start for Trial Regulations in Europe?over 3 years ago
A Lesson Learned in Patient Centricityover 3 years ago
In Memoriam: Michael J. Hennessy, Sr. (1960-2021)almost 4 years ago
Concerns Mount Over Limited Evidence for Accelerated Approvalsalmost 4 years ago
Asian Biotech Clinical Trial Demand Moves to the Westalmost 4 years ago
Creating Future-Ready Teams for Digital Clinical TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
